BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2899380)

  • 1. On the relationship between incorporation of 32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cells.
    Pecivová J; Drábiková K; Jancinová V; Nosál R
    Agents Actions; 1988 Apr; 23(3-4):146-8. PubMed ID: 2899380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-adrenoceptor blocking drugs on 32P incorporation into and arachidonic acid liberation from phospholipids in stimulated rat mast cells.
    Pecivová J; Drábiková K; Nosál R
    Agents Actions; 1989 Apr; 27(1-2):29-32. PubMed ID: 2568743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of adrenergic beta receptor blockers on phospholipid metabolism in mast cells].
    Pecivová J; Drábiková K; Nosál' R
    Bratisl Lek Listy; 1990 May; 91(5):363-8. PubMed ID: 1974476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-adrenoceptor blocking drugs on histamine liberation, prostaglandin synthesis and phospholipid turnover in isolated mast cells stimulated with concanavalin A.
    Drábiková K; Pecivová J; Petríková M; Jancinová V; Nosál R
    Agents Actions; 1990 Apr; 30(1-2):77-80. PubMed ID: 1695467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the interaction of beta-adrenoceptor-blocking drugs with isolated mast cells.
    Nosál R; Pecivová J; Drábiková K
    Agents Actions; 1985 Sep; 16(6):478-84. PubMed ID: 2416205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atenolol, exaprolol and mast cell membranes.
    Pecivová J; Drábiková K; Jancinová V; Petríková M; Nosál R
    Agents Actions; 1991 May; 33(1-2):41-3. PubMed ID: 1680276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking drugs and calcium transport in isolated rat mast cells.
    Drábiková K; Pecivová J; Nosál R
    Agents Actions; 1989 Apr; 27(1-2):33-5. PubMed ID: 2473626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells.
    Nosál R; Drábiková K; Pecivová J; Ondrias K
    Agents Actions; 1989 Apr; 27(1-2):36-8. PubMed ID: 2473627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
    Jancinová V; Nosál R
    Thromb Res; 1989 Jun; 54(6):687-98. PubMed ID: 2571198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amine transport in isolated rat mast cells treated with betaadrenoceptor blocking drugs.
    Nosál R; Pecivová J; Drábiková K
    Agents Actions; 1986 Apr; 18(1-2):74-6. PubMed ID: 2873725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for intracellular histamine liberation in isolated rat mast cells.
    Nosál R; Pecivova J; Drábiková K
    Agents Actions; 1982 Dec; 12(5-6):601-7. PubMed ID: 6187191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
    Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
    Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine liberation as a result of nonreceptor interaction.
    Nosál R; Drábiková K; Pecivová J; Jakubovský J
    Agents Actions; 1990 Apr; 30(1-2):74-6. PubMed ID: 1695466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chloroquine on mast cell membranes.
    Pecivová J; Drábiková K; Nosál R
    Agents Actions; 1994 Jun; 41 Spec No():C43-4. PubMed ID: 7976803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of beta-adrenergic blocking drugs and inhibitors of phosphodiestease on histamine release from isolated mast cells.
    Nosál R; Menyhardtová Z
    Agents Actions; 1977 Jul; 7(2):231-6. PubMed ID: 70989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the tridecamer of compound 48/80, a Ca2+-dependent histamine releaser, on phospholipid metabolism during the early stage of histamine release from rat mast cells.
    Dainaka J; Ichikawa A; Koibuchi Y; Nakagawa M; Tomita K
    Biochem Pharmacol; 1986 Nov; 35(21):3739-44. PubMed ID: 3778503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of histamine liberation. Cationic amphiphilic drugs and mast cells.
    Nosál R
    J Physiol Pharmacol; 1994 Sep; 45(3):377-86. PubMed ID: 7531010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of beta-adrenoceptor blocking drugs on the release of 5-hydroxytryptamine from isolated mast cells (author's transl)].
    Drábiková K; Pecivová J; Nosál R
    Bratisl Lek Listy; 1981 Jul; 76(1):52-60. PubMed ID: 6114788
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative relationship between histamine and 35S release from isolated rat mast cells due to the beta-adrenoceptor blocking drug Kö 1124.
    Nosál R; Pecivoá J; Drábikova K
    Biochem Pharmacol; 1981 Jun; 30(12):1693-5. PubMed ID: 6168269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.